Lee Scott Golden Receives Stock Award at PTC Therapeutics Inc (PTCT) — SEC Form 4, Jan 06, 2026
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Equity Position
95.3K sh
76,526 → 95,276
Equity Change
+24.5%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Lee Scott Golden CIK 0001686217 |
EVP
|
Lee Scott Golden at PTC Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,081,515
More from this insider at PTC Therapeutics Inc
| 2026-04-06 | Sell | -$56,364 | View |
| 2026-03-09 | Sell | -$633,800 | View |
| 2026-02-20 | Sell | -$172,290 | View |
| 2026-01-12 | Sell | -$66,206 | View |
| 2026-01-08 | Sell | -$152,855 | View |
Non-Derivative Securities Transactions
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $76.74 | 2026-01-02 | A - Award/Grant | 46,875 A | $0.00 | 2036-01-01 | 46,875 Common Stock | Direct |
Footnotes (3)
- F1
- Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027. Show more
- F2
- Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025. Show more
- F3
- This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027. Show more
Related filings at PTC Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
384
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $1.14B
- Rtw Investments, Lp $632M
- Jupiter Topco Llc $590M
5%+ Holders · 13D/G
5 filers
Other insiders at PTC Therapeutics Inc
-
Michael Schmertzler -$149K
-
Mark Elliott Boulding -$12.3K
-
Michael Schmertzler -$158K
-
Mark Elliott Boulding -$133K
-
Md Steele Glenn Phd Jr -$782K
GET /v1/forms/4/0001686217-26-000002
API docs
View Original SEC Filing